FDA awards Kuros Biosciences 510(k) approval for TLIF cage — 3 insights

Kuros Biosciences received FDA 510(k) approval for its transforaminal lumbar interbody fusion cage.

Advertisement

What you should know:

1. Kuros developed the TLIF cage for use with its spinal fusion product candidate KUR-113. The FDA cleared the cage for use in the lumbar spine with autograft and/or allograft.

2. With the approval, Kuros will begin a clinical trial studying the two products in patients.

3. The TLIF cage comes in several sizes and includes instrumentation.

More articles on devices: 
Humana launches bundled payments for spinal fusions at 4 practices, expands joint replacement program
29 spine, neurosurgeons on the move this year so far
Is price transparency positive or negative for spine? 3 surgeons weigh in

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.